Researchers from the National Institutes of Health (NIH) are applying artificial intelligence to the recruitment of ...
GSK has reported promising results with a drug to treat the severe itching that plagues patients with rare cholestatic liver ...
Top-line results show that 64.7% of patients achieved clear or almost clear skin measured using the Investigator's Global ...
"Astellas stands by the clinical profile of Izervay, the only FDA-approved GA treatment that consistently demonstrated ...
Grifols is anticipating a period of strong growth on the back of its recently FDA-approved intravenous immunoglobulin product ...
The trial of the PanEcho software, presented at the American Heart Association (AHA) congress in Chicago, suggests that it ...
The trial of the PanEcho software, presented at the American Heart Association (AHA) congress in Chicago, suggests that it ...
In an update posted today, Neurogene said that the "emerging treatment-related serious adverse event (SAE)" was a case of systemic hyperinflammatory syndrome, a rare and life-threatening immune ...